| 前收市價 | 3.0000 |
| 開市 | 3.0000 |
| 買盤 | 2.0500 |
| 賣出價 | 4.3000 |
| 拍板 | 42.50 |
| 到期日 | 2024-07-19 |
| 今日波幅 | 3.0000 - 3.0000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 8 |
InvestorPlaceGenomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
Genomics is the future of medicine. With it, companies are racing to shed light on human health and disease. Over the last two decades, related studies have allowed us to create genetic risk scores. For example, millions of people can get a better idea of developing a disease based on individual genetics. Also, this is creating big opportunity for some of the best genomics stock picks. “Genomics has given us a more comprehensive understanding of genetic risk factors for complex traits (body mass
Insider MonkeyTwist Bioscience Corporation (NASDAQ:TWST) Q2 2024 Earnings Call Transcript
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2024 Earnings Call Transcript May 2, 2024 Twist Bioscience Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to Twist Bioscience’s Fiscal 2024 Second Quarter Financial Results Conference Call. At this time, all participants […]
ZacksTwist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) delivered earnings and revenue surprises of 5.95% and 6.49%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
